题名

化學治療引起的突發性噁心嘔吐的檢視

DOI

10.6666/ClinMed.2017.80.2.088

作者

李耀泰;陳福民;郭宗正

关键词

化學治療 ; 突發性噁心嘔吐(breakthrough nausea and vomiting) ; 預防性止吐藥(prophylactic antiemetics)

期刊名称

臨床醫學月刊

卷期/出版年月

80卷2期(2017 / 08 / 25)

页次

475 - 478

内容语文

繁體中文

中文摘要

對高致吐和中致吐化學治療,基本上會使用預防性止吐藥物,但少數患者仍會發生噁心嘔吐,稱之為突發性噁心嘔吐,會導致患者相當不適,甚至要放棄化療,就等於化療失敗,此時救援性止吐治療極顯重要。故在治療前須先分析致吐的危險因子、是否存在其它致吐的疾病或藥物、預防性止吐藥物的種類和劑量是否得宜等。治療突發性噁心嘔吐的藥物,原則上應與預防性的藥物不同,其中口服使用olanzapine和aprepitant效果很好,對嚴重嘔吐無法口服藥物者,可採藥物注射或皮膚貼片。同時在下次化療前,可考慮同時使用救援藥物來預防突發性噁心嘔吐。

主题分类 醫藥衛生 > 基礎醫學
醫藥衛生 > 社會醫學
参考文献
  1. Basch, E,Prestrud, AA,Hesketh, PJ(2011).Antiemetic American Society of Clinical Oncology clinical practice guideline update.J Clin Oncol,29,4189-4198.
  2. Boccia, RV,Gordan, LN,Clark, G(2011).Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, doubleblind, phase III study.Support Care Cancer,19,1609-1617.
  3. Chiu, L,Chiu, N,Chow, R(2016).Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a retrospective study.Ann Palliat Med,5,172-178.
  4. de Wit, R,de Boer, AC,vd Linden, GHM(2001).Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy.Br J Cancer,85,1099-1101.
  5. Inoue, T,Kimura, M,Uchida, J(2017).Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.Int J Clin Oncol,22,600-604.
  6. Lau, TKH,Yip, CHW,Yeo, W(2016).State of the art antiemetic therapy for cancer patients.Curr Oncol Rep,18,2.
  7. Navari, RM,Nagy, CK,Gray, SE(2013).The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.Support Care Cancer,21,1655-1663.
  8. Roila, F,Herrstedt, J,Aapro, M(2010).Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.Ann Oncol,21,232-243.
  9. Tamura, K,Aiba, K,Saeki, T(2017).Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan.Int J Clin Oncol,22,405-412.
  10. Yang, LQ,Sun, XC,Qin, SK(2016).Transdermal granisetron for the prevention of nausea and vomiting following moderatelyor highly emetogenic chemotherapy in Chinese patients: a randomized, doubleblind, phase III study.Chin Clin Oncol,5,79e1-79e8.
被引用次数
  1. 張月如(Yue-Ru Jhang);江迎星(Ying-Hsing Chiang)(2023)。癌症化療患者介入音樂治療是否可改善噁心嘔吐。彰化護理。30(2)。28-36。 
  2. 劉瑞靈(2018)。結直腸癌病人在化療期間症狀困擾、焦慮與憂鬱預測因子之探討。義守大學護理學系學位論文。2018。1-72。